# aTYR PHARMA INC (ATYR) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from aTYR PHARMA INC's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/ATYR/mda/fy2025/): filed 2026-03-05; accession 0001339970-26-000008 (https://www.sec.gov/Archives/edgar/data/1339970/000133997026000008/atyr-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/ATYR/mda/fy2024/): filed 2025-03-13; accession 0000950170-25-038888 (https://www.sec.gov/Archives/edgar/data/1339970/000095017025038888/atyr-20241231.htm)
- [FY 2023 MD&A](/company/ATYR/mda/fy2023/): filed 2024-03-14; accession 0000950170-24-031584 (https://www.sec.gov/Archives/edgar/data/1339970/000095017024031584/life-20231231.htm)
- [FY 2022 MD&A](/company/ATYR/mda/fy2022/): filed 2023-03-14; accession 0000950170-23-007873 (https://www.sec.gov/Archives/edgar/data/1339970/000095017023007873/life-20221231.htm)
- [FY 2021 MD&A](/company/ATYR/mda/fy2021/): filed 2022-03-15; accession 0001564590-22-010441 (https://www.sec.gov/Archives/edgar/data/1339970/000156459022010441/life-10k_20211231.htm)

Back to /company/ATYR/